Case Reports in Pulmonology
Volume 2013 (2013), Article ID 813786, 3 pages
http://dx.doi.org/10.1155/2013/813786
Case Report
The Commonwealth Medical College, Pocono Medical Center, 175 East Brown Street, Suite 203, East Stroudsburg, PA 18301, USA
Received 10 June 2013; Accepted 5 August 2013
Academic Editors: F. J. Aspa, L. Borderías, G. Hillerdal, H. Matsuoka, and H. Niwa
Copyright © 2013 Samer Alkhuja et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
A 16-year-old Caucasian female presented to the pulmonary clinic for a followup on her asthma. Due to the worsening of allergy-related symptoms, therapy with montelukast 10 mg daily was started and resulted in good relief of the patient’s symptoms. In the nights following initiating therapy with montelukast, the patient’s mother reported daily parasomnias in the form of sleeptalking and sleepwalking. Montelukast was discontinued, and that resulted in absence of the parasomnias. In a second attempt montelukast was reinstituted to control the patient’s symptoms. Parasomnias were immediately reported after resuming therapy. Montelukast was then discontinued indefinitely. Our patient has never had any history of parasomnias, and since the discontinuation of montelukast, parasomnias were never reported again. Parasomnias in the form of sleeptalking or sleepwalking were not previously reported as adverse effects of montelukast. Alternative modalities to treat allergy-related symptoms in patients, who develop parasomnias while receiving montelukast, should be explored.
No comments:
Post a Comment